Use of Transcriptomics in Understanding Mechanisms of Drug-induced Toxicity

Overview

Journal Pharmacogenomics

Specialties Genetics
Pharmacology

Date 2010 Mar 31

PMID 20350139

Citations 39

Authors

Yuxia Cui

Richard S Paules

Affiliations

Soon will be listed here.

Abstract

Adverse drug reactions (ADRs) are an important clinical issue and a serious public health risk. Understanding the underlying mechanisms is critical for clinical diagnosis and management of different ADRs. Toxicogenomics can reveal impacts on biological pathways and processes that had not previously been considered to be involved in a drug response. Mechanistic hypotheses can be generated that can then be experimentally tested using the full arsenal of pharmacology, toxicology, molecular biology and genetics. Recent transcriptomic studies on drug-induced toxicity, which have provided valuable mechanistic insights into various ADRs, have been reviewed with a focus on nephrotoxicity and hepatotoxicity. Related issues have been discussed, including extrapolation of mechanistic findings from experimental model systems to humans using blood as a surrogate tissue for organ damage and comparative systems biology approaches.

Citing Articles

Urinary bioorthogonal reporters for the monitoring of the efficacy of chemotherapy for lung cancer and of associated kidney injury.

Cheng P, Zeng Z, Liu J, Liew S, Hu Y, Xu M Nat Biomed Eng. 2025; .

PMID: 39880894 DOI: 10.1038/s41551-024-01340-1.

Artificial Intelligence and Machine Learning Models for Predicting Drug-Induced Kidney Injury in Small Molecules.

Rao M, Nassiri V, Srivastava S, Yang A, Brar S, McDuffie E Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598459 PMC: 11597314. DOI: 10.3390/ph17111550.

The Antioxidant and Hepatoprotective Potential of Berberine and Silymarin on Acetaminophen Induced Toxicity in L.

Gradinariu L, Dediu L, Cretu M, Grecu I, Docan A, Istrati D Animals (Basel). 2024; 14(3).

PMID: 38338016 PMC: 10854737. DOI: 10.3390/ani14030373.

Next-generation sequencing reveals altered gene expression and enriched pathways in triple-negative breast cancer cells treated with oleuropein and oleocanthal.

Karousi P, Kontos C, Papakotsi P, Kostakis I, Skaltsounis A, Scorilas A Funct Integr Genomics. 2023; 23(4):299.

PMID: 37707691 PMC: 10501944. DOI: 10.1007/s10142-023-01230-w.

A tiered testing strategy based on in vitro phenotypic and transcriptomic data for selecting representative petroleum UVCBs for toxicity evaluation in vivo.

Tsai H, House J, Wright F, Chiu W, Rusyn I Toxicol Sci. 2023; 193(2):219-233.

PMID: 37079747 PMC: 10230285. DOI: 10.1093/toxsci/kfad041.

References

Kramer J, Pettit S, Amin R, Bertram T, Car B, Cunningham M . Overview on the application of transcription profiling using selected nephrotoxicants for toxicology assessment. Environ Health Perspect. 2004; 112(4):460-4. PMC: 1241900. DOI: 10.1289/ehp.6673. View

Leussink B, Baelde H, Broekhuizen-van den Berg T, de Heer E, van der Voet G, Slikkerveer A . Renal epithelial gene expression profile and bismuth-induced resistance against cisplatin nephrotoxicity. Hum Exp Toxicol. 2003; 22(10):535-40. DOI: 10.1191/0960327103ht393oa. View

Blomme E, Ciurlionis R, Marsh K, Waring J, Yang Y . Evaluation of the effects of serial phlebotomy on the transcriptome of major tissues and on the response to toxicants in rats. Toxicol Lett. 2008; 176(2):138-48. DOI: 10.1016/j.toxlet.2007.09.014. View

Bushel P, Heinloth A, Li J, Huang L, Chou J, Boorman G . Blood gene expression signatures predict exposure levels. Proc Natl Acad Sci U S A. 2007; 104(46):18211-6. PMC: 2084322. DOI: 10.1073/pnas.0706987104. View

Lazarou J, Pomeranz B, Corey P . Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998; 279(15):1200-5. DOI: 10.1001/jama.279.15.1200. View

Edwards I, Aronson J . Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000; 356(9237):1255-9. DOI: 10.1016/S0140-6736(00)02799-9. View

Bammert G, Fostel J . Genome-wide expression patterns in Saccharomyces cerevisiae: comparison of drug treatments and genetic alterations affecting biosynthesis of ergosterol. Antimicrob Agents Chemother. 2000; 44(5):1255-65. PMC: 89853. DOI: 10.1128/AAC.44.5.1255-1265.2000. View

Hamadeh H, Bushel P, Jayadev S, DiSorbo O, Bennett L, Li L . Prediction of compound signature using high density gene expression profiling. Toxicol Sci. 2002; 67(2):232-40. DOI: 10.1093/toxsci/67.2.232. View

Powell C, Kosyk O, Ross P, Schoonhoven R, Boysen G, Swenberg J . Phenotypic anchoring of acetaminophen-induced oxidative stress with gene expression profiles in rat liver. Toxicol Sci. 2006; 93(1):213-22. PMC: 1805881. DOI: 10.1093/toxsci/kfl030. View

10.

Blomme E, Yang Y, Waring J . Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development. Toxicol Lett. 2008; 186(1):22-31. DOI: 10.1016/j.toxlet.2008.09.017. View

11.

Uehara T, Hirode M, Ono A, Kiyosawa N, Omura K, Shimizu T . A toxicogenomics approach for early assessment of potential non-genotoxic hepatocarcinogenicity of chemicals in rats. Toxicology. 2008; 250(1):15-26. DOI: 10.1016/j.tox.2008.05.013. View

12.

Moore T, Cohen M, Furberg C . Serious adverse drug events reported to the Food and Drug Administration, 1998-2005. Arch Intern Med. 2007; 167(16):1752-9. DOI: 10.1001/archinte.167.16.1752. View

13.

Auman J, Chou J, Gerrish K, Huang Q, Jayadev S, Blanchard K . Identification of genes implicated in methapyrilene-induced hepatotoxicity by comparing differential gene expression in target and nontarget tissue. Environ Health Perspect. 2007; 115(4):572-8. PMC: 1852695. DOI: 10.1289/ehp.9396. View

14.

Burczynski M, Dorner A . Transcriptional profiling of peripheral blood cells in clinical pharmacogenomic studies. Pharmacogenomics. 2006; 7(2):187-202. DOI: 10.2217/14622416.7.2.187. View

15.

Chao A, Wang T, Lee Y, Hong J, Tsai C, Chen C . Analysis of functional groups of differentially expressed genes in the peripheral blood of patients with cervical cancer undergoing concurrent chemoradiation treatment. Radiat Res. 2007; 169(1):76-86. DOI: 10.1667/RR1045.1. View

16.

Beyer R, Fry R, Lasarev M, McConnachie L, Meira L, Palmer V . Multicenter study of acetaminophen hepatotoxicity reveals the importance of biological endpoints in genomic analyses. Toxicol Sci. 2007; 99(1):326-37. DOI: 10.1093/toxsci/kfm150. View

17.

Showe M, Vachani A, Kossenkov A, Yousef M, Nichols C, Nikonova E . Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease. Cancer Res. 2009; 69(24):9202-10. PMC: 2798582. DOI: 10.1158/0008-5472.CAN-09-1378. View

18.

Gandhi T, Weingart S, Borus J, Seger A, Peterson J, Burdick E . Adverse drug events in ambulatory care. N Engl J Med. 2003; 348(16):1556-64. DOI: 10.1056/NEJMsa020703. View

19.

Huang Q, Dunn 2nd R, Jayadev S, DiSorbo O, Pack F, Farr S . Assessment of cisplatin-induced nephrotoxicity by microarray technology. Toxicol Sci. 2001; 63(2):196-207. DOI: 10.1093/toxsci/63.2.196. View

20.

Reilly T, Brady J, Marchick M, Bourdi M, George J, Radonovich M . A protective role for cyclooxygenase-2 in drug-induced liver injury in mice. Chem Res Toxicol. 2001; 14(12):1620-8. DOI: 10.1021/tx0155505. View